This federal contract award is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,624.96 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 5, 2024. This delivery order contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Generated 3/6/25, 9:49 AM